← Open Payments lookup

XINXIN TANG: Open Payments

NPI 1487087144 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$430 in 14 payments from 8 companies in 2025. Trend: 2023 $450 · 2024 $719 · 2025 $430

Food & beverage: $321Education: $109
CompanyPaymentsAmount
Lilly USA, LLC2$142
Karyopharm Therapeutics Inc.2$63
Celgene Corporation2$56
Exact Sciences Corporation2$48
Exelixis Inc.2$45
BTG International Inc.2$40
ADC THERAPEUTICS AMERICA, INC.1$20
Novo Nordisk Inc1$15

Products named: JAYPIRCA, XPOVIO, Cologuard Collection Kit, CABOMETYX, VORAXAZE, REBLOZYL, BREYANZI, ZYNLONTA.

Industry payments across TX — which companies pay providers there.